# Amplified Sciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amplified-sciences

- Industry: Biotechnology
- Headquarters: West Lafayette, US
- Website: www.amplifiedsciences.com
- Total disclosed funding: $2.6M
- Latest round: Seed (Nov 25, 2024)
- Investors on record: 6

## About

Based in Indiana, US, and founded in 2016 by CEO Diana T. Caldwell and V. Jo Davisson, Amplified Sciences, LLC, a.k.a. Amplified Sciences is a life science diagnostics company focused on accurately detecting and preempting the risks of debilitating diseases. With operations in Purdue Research Park and key alliances in San Francisco and Boston, the company’s lead assay is for the early detection of pancreatic cancer. In February 2024, Amplified Sciences, Inc. raised an amount of USD 0.108 million in venture funding.

The company develops a platform based on ultra-sensitive molecular sensing technology to treat pancreatic cancer. The platform can detect at the single molecule level, scales easily to the point of care, and provides a favorable cost structure for their platform of reagents.

Amplified Sciences plans to use its proceeds from February 2024 funding to develop its tests for early, more accurate detection of challenging diseases, starting with pancreatic cancer.

## Funding rounds

- Seed, Nov 25, 2024, $2.6M — OCA Ventures, Elevate Ventures, VisionTech Partners, IU Ventures, Flywheel Fund, Purdue Innovates

## Investors

- OCA Ventures (https://capitalatlas.ai/funds/oca-ventures) — Seed
- Elevate Ventures (https://capitalatlas.ai/funds/elevate-ventures) — Seed
- VisionTech Partners (https://capitalatlas.ai/funds/visiontech-partners) — Seed
- IU Ventures — Seed
- Flywheel Fund (https://capitalatlas.ai/funds/flywheel-fund) — Seed
- Purdue Innovates — Seed